Legend Biotech Corp (LEGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.39B
Last updated: Nov 17, 2026 at 11:06 AM ET
Legend Biotech Corp (LEGN) Competitors
The companies most similar to Legend Biotech are Beam Therapeutics (BEAM), Vir Biotechnology (VIR) and Disc Medicine (IRON). By market cap, Legend Biotech ranks 5th of the 13 companies on this page; Cogent Biosciences (COGT) is the largest at $4.97B.
Peer Comparison
LEGN's revenue growth of 32.0% is above the peer median of -31.8%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Legend Biotech (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Disc Medicine Inc. (IRON) | $3.64B | N/A | N/A | 0.0% | -40.0% | 0.0% | 0.00% |
| MBX Biosciences, Inc. Common Stock (MBX) | $2.78B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Vericel Corp Ord (VCEL) | $2.91B | 89.8x | 9.1x | 10.3% | N/A | 26.5% | 0.00% |
| Cogent Biosciences Inc (COGT) | $4.97B | N/A | N/A | 0.0% | -43.4% | -100.0% | 0.00% |
| Telix Pharmaceuticals Limited (TLX) | $3.14B | N/A | 5.3x | 3.8% | -0.7% | 22.3% | 0.00% |
| Celldex Therapeutics Inc (CLDX) | $2.26B | N/A | N/A | 0.0% | N/A | -97.0% | 0.00% |
| Arcus Biosciences Inc (RCUS) | $2.51B | N/A | 21.5x | 0.0% | -75.9% | -65.4% | 0.00% |
| Xenon Pharmaceuticals Inc (XENE) | $3.98B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Dyne Therapeutics Inc (DYN) | $3.22B | N/A | N/A | 0.0% | -42.9% | 0.0% | 0.00% |
| Peer median | $3.02B | 89.8x | 12.0x | 0.0% | -41.8% | -31.8% | 0.00% |
Similar Companies
These are the 12 companies most similar to Legend Biotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Disc Medicine Inc. (IRON) | Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development... | IRON competitors |
| MBX Biosciences, Inc. Common Stock (MBX) | MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment... | MBX competitors |
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
| Vericel Corp Ord (VCEL) | Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures... | VCEL competitors |
| Cogent Biosciences Inc (COGT) | Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. | COGT competitors |
| Telix Pharmaceuticals Limited (TLX) | Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic... | |
| Celldex Therapeutics Inc (CLDX) | Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment... | CLDX competitors |
| Arcus Biosciences Inc (RCUS) | Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. | RCUS competitors |
| Xenon Pharmaceuticals Inc (XENE) | Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders... | XENE competitors |
| Dyne Therapeutics Inc (DYN) | Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases... | DYN competitors |
Frequently Asked Questions About LEGN
Who are Legend Biotech's main competitors?
The companies most similar to Legend Biotech include Beam Therapeutics (BEAM), Vir Biotechnology (VIR), Disc Medicine (IRON), MBX Biosciences, Inc. Common Stock (MBX) and Viridian Therapeutics (VRDN), listed from the closest match.
Who is Legend Biotech's biggest competitor?
Cogent Biosciences (COGT) is the largest of the similar companies at $4.97B; Beam Therapeutics (BEAM) is the closest match by business profile, size, sector and industry.
How does LEGN stock compare with its competitors?
LEGN's P/E is 266.5x against a peer median of 89.8x; its P/S is 2.3x against a peer median of 12.0x; its net margin is -0.0% against a peer median of 0.0%.
Which of Legend Biotech's competitors pays a higher dividend?
Legend Biotech pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Legend Biotech bigger than its competitors?
No. Legend Biotech is 5th by market cap among the 13 companies on this page; the largest is Cogent Biosciences (COGT) at $4.97B.
LEGN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors